We perform an econometric investigation of the contribution of pharmaceutical innovation to mortality reduction and … pharmaceutical innovation, there would have been no increase and perhaps even a small decrease in mean age at death, and that new … drugs have increased life expectancy, and lifetime income, by about 0.75-1.0% per annum. The drug innovation measures are …

We perform an econometric investigation of the contribution of pharmaceutical innovation to mortality reduction and … pharmaceutical innovation, there would have been no increase and perhaps even a small decrease in mean age at death, and that new … drugs have increased life expectancy, and lifetime income, by about 0.75-1.0% per annum. The drug innovation measures are …

understanding of the role of medical innovation in this process. Specifically, what are the causal effects of medical innovation on … medical innovation and test the model’s implications empirically. We show that a causal pathway from medical innovation to … following way: in early stages of development, medical innovation does not have a positive effect on economic growth, whereas in …